Haemonetics describes its machines as the most popular devices used at plasma collection centers, the facilities where donors are paid to give plasma. CSL Plasma, the largest of those plasma ...

Blood products company Haemonetics (NYSE:HAE). reported Q2 CY2025 results , but sales fell by 4.4% year on year to $321.4 million. Its non-GAAP profit of $1.10 per share was 8.3% above analysts’ ...

Blood products company Haemonetics (NYSE:HAE). reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 5.3% year on year to $327.3 million. Its non-GAAP profit of $1.27 per ...

Blood products company Haemonetics (NYSE:HAE). in Q1 CY2025, but sales fell by 3.7% year on year to $330.6 million. Its non-GAAP profit of $1.24 per share was 1.6% above analysts’ consensus estimates.

In recent weeks, Needham & Co.'s team of medtech analysts met with a series of investors across several regions of the United States. Earlier this week we shared their insights on AtriCure.

Good day, and thank you for standing by. Welcome to the Q4 2024 Haemonetics Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' ...